HQL logo

Tekla Life Sciences Investors (HQL) Return On Equity

Annual ROE

18.56%
+13.00%+233.81%

30 September 2024

HQL ROE Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HQL ROE Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+233.8%-
3 y3 years+50.5%-
5 y5 years--

HQL ROE High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+170.6%
5 y5 yearsat high+170.6%
alltimeall timeat high+170.6%

Tekla Life Sciences Investors ROE History

DateAnnualQuarterly
Sept 2024
18.56%(+233.8%)
-
Sept 2023
5.56%(-121.1%)
-
DateAnnualQuarterly
Sept 2022
-26.29%(-313.2%)
-
Sept 2021
12.33%
-

FAQ

  • What is Tekla Life Sciences Investors annual return on equity?
  • What is the all time high annual ROE for Tekla Life Sciences Investors?
  • What is Tekla Life Sciences Investors annual ROE year-on-year change?

What is Tekla Life Sciences Investors annual return on equity?

The current annual ROE of HQL is 18.56%

What is the all time high annual ROE for Tekla Life Sciences Investors?

Tekla Life Sciences Investors all-time high annual return on equity is 18.56%

What is Tekla Life Sciences Investors annual ROE year-on-year change?

Over the past year, HQL annual return on equity has changed by +13.00% (+233.81%)